Essentialpharmagroup
1 known investors
Essential Pharma develops, manufactures and delivers medicines for patients in small, underserved or rare disease populations, including therapies at risk of discontinuation. Its portfolio covers therapeutic areas such as rare disease, CNS, ophthalmology and gastroenterology, reaching patients in around 70 countries, and its pipeline includes an anti-GD2 antibody for high-risk neuroblastoma.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Essentialpharmagroup do?
- Essential Pharma develops, manufactures and delivers medicines for patients in small, underserved or rare disease populations, including therapies at risk of discontinuation. Its portfolio covers therapeutic areas such as rare disease, CNS, ophthalmology and gastroenterology, reaching patients in around 70 countries, and its pipeline includes an anti-GD2 antibody for high-risk neuroblastoma.
- Who are Essentialpharmagroup's investors?
- Essentialpharmagroup's investors include B Capital.